1
|
Obstructive sleep apnea syndrome: An important piece in the puzzle of cardiovascular risk factors. CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS 2014; 27:256-63. [PMID: 25496654 DOI: 10.1016/j.arteri.2014.10.002] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/08/2014] [Revised: 09/30/2014] [Accepted: 10/01/2014] [Indexed: 11/20/2022]
Abstract
The obstructive sleep apnea syndrome (OSA) is a clinical entity characterized by recurring episodes of apnea and/or hypopnea during sleep, due to a total or partial collapse, respectively, of the upper airway. This collapse originates a set of pathophysiological changes that determine the appearance of several cardiovascular complications. OSA contributes for the development of hypertension, heart failure, arrhythmias and coronary heart disease. Nowadays it is recognized to be an important public health problem, taking into account not just its repercussions but also its prevalence, since the main risk factor for the disease is obesity, a growing problem worldwide, both in developed and developing countries. The present review summarizes the current knowledge about OSA, as regards its definition, pathophysiology, clinical manifestations, diagnosis, cardiovascular effects and treatment.
Collapse
|
2
|
Ding WX, Dong YB, Ding N, Zhang XF, Zhang SJ, Zhang XL, Liu JN, Lu G. Adiponectin protects rat heart from left ventricular remodeling induced by chronic intermittent hypoxia via inhibition of TGF-β/smad2/3 pathway. J Thorac Dis 2014; 6:1278-84. [PMID: 25276370 DOI: 10.3978/j.issn.2072-1439.2014.07.44] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2014] [Accepted: 07/21/2014] [Indexed: 12/22/2022]
Abstract
OBJECTIVE Obstructive sleep apnea syndrome (OSAS) is associated with many cardiovascular disorders. Chronic intermittent hypoxia (CIH) is the primary player in OSAS of the many associated factors. This study was in order to investigate the effects of the Adiponectin (Ad) on left ventricular remodeling induced by CIH. METHODS Forty-five rats were randomly divided into three groups: normal control (NC) group, CIH group and CIH plus Ad supplemented (CIH + Ad) group. After 35 days' CIH exposure, masson analysis was used to detect the left ventricular fibrosis and western blot was used to measure the protein expression of collagen I, collagen III and TGF-β/smad2/3 pathway. Gene analysis by RT-PCR was used to study the MMP2 and TIMP2. RESULTS After CIH exposure, the fibrosis of left ventricular in CIH group was significantly remarkable than that in both NC and CIH + Ad groups (P<0.05), although statistical difference existed between NC and CIH + Ad groups (P<0.05). In addition, the protein expression of collagen I as well as collagen III and the ratio of mRNA levels of MMP2/TIMP2 were the highest in CIH group but the lowest in NC group, with CIH + Ad group in between. There was a significant difference among three groups (all P<0.05). The TGF-β/smad2/3 pathway was activated obviously in CIH group, but less noticeably in CIH + Ad group (P<0.05) with a significant difference in the two groups. CONCLUSIONS The present study showed that Ad could ameliorate the left ventricular remodeling induced by CIH via inhibition of the expression of TGF-β/smad2/3 pathway.
Collapse
Affiliation(s)
- Wen-Xiao Ding
- 1 Department of Respiratory Medicine, 2 Department of Cardiothoracic Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China ; 3 Department of Respiratory Diseases, Jiangsu Geriatric Hospital, Nanjing 210024, China
| | - Yan-Bin Dong
- 1 Department of Respiratory Medicine, 2 Department of Cardiothoracic Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China ; 3 Department of Respiratory Diseases, Jiangsu Geriatric Hospital, Nanjing 210024, China
| | - Ning Ding
- 1 Department of Respiratory Medicine, 2 Department of Cardiothoracic Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China ; 3 Department of Respiratory Diseases, Jiangsu Geriatric Hospital, Nanjing 210024, China
| | - Xiao-Feng Zhang
- 1 Department of Respiratory Medicine, 2 Department of Cardiothoracic Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China ; 3 Department of Respiratory Diseases, Jiangsu Geriatric Hospital, Nanjing 210024, China
| | - Shi-Jiang Zhang
- 1 Department of Respiratory Medicine, 2 Department of Cardiothoracic Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China ; 3 Department of Respiratory Diseases, Jiangsu Geriatric Hospital, Nanjing 210024, China
| | - Xi-Long Zhang
- 1 Department of Respiratory Medicine, 2 Department of Cardiothoracic Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China ; 3 Department of Respiratory Diseases, Jiangsu Geriatric Hospital, Nanjing 210024, China
| | - Jian-Nan Liu
- 1 Department of Respiratory Medicine, 2 Department of Cardiothoracic Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China ; 3 Department of Respiratory Diseases, Jiangsu Geriatric Hospital, Nanjing 210024, China
| | - Gan Lu
- 1 Department of Respiratory Medicine, 2 Department of Cardiothoracic Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China ; 3 Department of Respiratory Diseases, Jiangsu Geriatric Hospital, Nanjing 210024, China
| |
Collapse
|